我国中小生物医药企业危机管理研究
发布时间：2019-03-03 15:17
【摘要】：企业危机管理是近期许多学者和管理者高度关注及热衷研究的一门学科，企业危机管理的核心是危机发生之前，提前预知、有预案，危机来临时如何合理及时地按预案处理，危机发生后如何科学地管理及时总结，纳入新的危机管理程序中去，使得危机管理是推动企业发展的动力。 中小生物医药企业在自身发展过程中，受环境和行业特征的影响，导致企业时常处于危机之中。由于中小生物医药企业具有中小企业的普遍性特点外，，还有自身所处行业的复杂性特点，深刻把握此类企业危机形成的机理，构建中小生物医药企业危机管理模型，总结中小生物医药企业进行危机管理的策略是本文研究的主要内容。 本文首先结合国内外众多学者的研究成果，从多方面，多角度地对危机及危机管理的概念进行了描述，尽量全方位地了解危机及危机管理。在此基础上，对我国中小生物医药企业的现状、危机来源及形成机理进行了探索和分析。在生物医药行业危机管理的研究方面我国起步较晚，能借鉴的资料和成果较少，尤其是针对我国生物医药行业存在的大多数中小企业来说，更是无从下手，因此运用危机管理的理论知识来探究、引导中小生物医药企业的危机管理实践就显得尤为重要。论文在对中小生物医药企业进行全面分析后，应用危机管理原理构建中小生物医药企业危机管理模型，并对模型进行了分析和阐述，提出在企业战略、核心团队、质量保障、资金链管理和信息沟通五个方面管理危机，并提出运用危机预防、危机处理和危机善后管理三大系统管控危机，希望对我国中小生物医药企业实现“有效进行危机预防控制，合理运用危机处理方式，积极参与危机善后管理”有所裨益。
[Abstract]:Enterprise crisis management is a subject that many scholars and managers pay close attention to and are keen to study recently. The core of enterprise crisis management is how to deal with it in a reasonable and timely manner before the crisis occurs, anticipates in advance, has a plan, and how to deal with it in a reasonable and timely manner when the crisis comes. In order to promote the development of enterprises, how to make a scientific and timely summary of the crisis management and bring it into the new crisis management procedure is the driving force for the development of the enterprise. Small and medium-sized biopharmaceutical enterprises are often in crisis because of the influence of environment and industry characteristics in their own development process. Small and medium-sized biopharmaceutical enterprises have not only the universal characteristics of small and medium-sized enterprises, but also the complexity characteristics of their own industries, deeply grasp the mechanism of crisis formation of such enterprises, and construct a crisis management model for small and medium-sized bio-pharmaceutical enterprises. It is the main content of this paper to summarize the strategy of crisis management in small and medium-sized biopharmaceutical enterprises. Based on the research results of many scholars at home and abroad, this paper describes the concept of crisis and crisis management from many aspects and perspectives, and tries to understand the crisis and crisis management as far as possible. On this basis, the status quo, crisis sources and formation mechanism of small and medium-sized biopharmaceutical enterprises in China were explored and analyzed. In the biological medicine industry crisis management research aspect our country starts late, can draw lessons from the data and the achievement is less, especially for our country biomedicine profession existence most small and medium-sized enterprises, it is impossible to start even more. Therefore, it is very important to use the theoretical knowledge of crisis management to explore and guide the practice of crisis management in small and medium-sized biopharmaceutical enterprises. After an overall analysis of the small and medium-sized biopharmaceutical enterprises, this paper applies the crisis management principle to construct the crisis management model of the small and medium-sized biopharmaceutical enterprises, analyzes and expounds the model, and puts forward the following aspects: enterprise strategy, core team, quality assurance, and so on. The management of crisis in five aspects of fund chain management and information communication, and put forward the use of crisis prevention, crisis management and crisis management system to control the crisis, hoping to achieve "effective crisis prevention and control for small and medium-sized bio-pharmaceutical enterprises in China," Rational use of crisis management, active participation in crisis management "is beneficial."
【学位授予单位】：天津大学
【学位级别】：硕士
【学位授予年份】：2013
【分类号】：F426.72;F272.3
[Abstract]:Enterprise crisis management is a subject that many scholars and managers pay close attention to and are keen to study recently. The core of enterprise crisis management is how to deal with it in a reasonable and timely manner before the crisis occurs, anticipates in advance, has a plan, and how to deal with it in a reasonable and timely manner when the crisis comes. In order to promote the development of enterprises, how to make a scientific and timely summary of the crisis management and bring it into the new crisis management procedure is the driving force for the development of the enterprise. Small and medium-sized biopharmaceutical enterprises are often in crisis because of the influence of environment and industry characteristics in their own development process. Small and medium-sized biopharmaceutical enterprises have not only the universal characteristics of small and medium-sized enterprises, but also the complexity characteristics of their own industries, deeply grasp the mechanism of crisis formation of such enterprises, and construct a crisis management model for small and medium-sized bio-pharmaceutical enterprises. It is the main content of this paper to summarize the strategy of crisis management in small and medium-sized biopharmaceutical enterprises. Based on the research results of many scholars at home and abroad, this paper describes the concept of crisis and crisis management from many aspects and perspectives, and tries to understand the crisis and crisis management as far as possible. On this basis, the status quo, crisis sources and formation mechanism of small and medium-sized biopharmaceutical enterprises in China were explored and analyzed. In the biological medicine industry crisis management research aspect our country starts late, can draw lessons from the data and the achievement is less, especially for our country biomedicine profession existence most small and medium-sized enterprises, it is impossible to start even more. Therefore, it is very important to use the theoretical knowledge of crisis management to explore and guide the practice of crisis management in small and medium-sized biopharmaceutical enterprises. After an overall analysis of the small and medium-sized biopharmaceutical enterprises, this paper applies the crisis management principle to construct the crisis management model of the small and medium-sized biopharmaceutical enterprises, analyzes and expounds the model, and puts forward the following aspects: enterprise strategy, core team, quality assurance, and so on. The management of crisis in five aspects of fund chain management and information communication, and put forward the use of crisis prevention, crisis management and crisis management system to control the crisis, hoping to achieve "effective crisis prevention and control for small and medium-sized bio-pharmaceutical enterprises in China," Rational use of crisis management, active participation in crisis management "is beneficial."
【学位授予单位】：天津大学
【学位级别】：硕士
【学位授予年份】：2013
【分类号】：F426.72;F272.3
【参考文献】
相关期刊论文 前5条
1 魏加宁;危机与危机管理[J];管理世界;1994年06期
2 赵定涛,李蓓;企业危机管理五力模型分析[J];科技进步与对策;2005年04期
3 熊学国;;企业危机管理浅析[J];科技经济市场;2007年11期
4 孟光兴,邱家学;医药企业实施多元化战略应考虑的两个问题——以罗氏剥离维生素部门为案例[J];上海医药;2003年10期
5 何苏湘;对企业危机管理的理论界定[J];商业经济研究;1998年05期
相关博士学位论文 前1条
1 徐一e
本文编号：2433818
本文链接：https://www.wllwen.com/guanlilunwen/shengchanguanlilunwen/2433818.html
